Morgan Stanley’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2 Buy
+1
New +$1 ﹤0.01% 8255
2025
Q4
Sell
-3,000
Closed -$6.21K 8245
2025
Q3
$6.21K Buy
3,000
+2,900
+2,900% +$8.12K ﹤0.01% 7033
2025
Q2
$196 Buy
100
+50
+100% +$91 ﹤0.01% 7572
2025
Q1
$87 Hold
50
﹤0.01% 7597
2024
Q4
$104 Hold
50
﹤0.01% 7461
2024
Q3
$149 Sell
50
-300
-86% -$884 ﹤0.01% 7403
2024
Q2
$1.1K Sell
350
-8,500
-96% -$29.5K ﹤0.01% 7142
2024
Q1
$46.3K Sell
8,850
-1,411
-14% -$5.8K ﹤0.01% 6242
2023
Q4
$25.4K Buy
10,261
+2,244
+28% +$4.88K ﹤0.01% 6577
2023
Q3
$17.8K Sell
8,017
-2,432
-23% -$8.74K ﹤0.01% 6522
2023
Q2
$55.7K Buy
10,449
+4,738
+83% +$30.4K ﹤0.01% 6170
2023
Q1
$35.4K Sell
5,711
-1,392
-20% -$11.2K ﹤0.01% 6407
2022
Q4
$91.6K Sell
7,103
-2,891
-29% -$53.3K ﹤0.01% 6013
2022
Q3
$230K Buy
9,994
+2,327
+30% +$70.6K ﹤0.01% 5665
2022
Q2
$260K Buy
7,667
+2,679
+54% +$218K ﹤0.01% 5764
2022
Q1
$435K Sell
4,988
-15
-0.3% -$899 ﹤0.01% 5495
2021
Q4
$256K Sell
5,003
-97
-2% -$6.2K ﹤0.01% 5931
2021
Q3
$361K Buy
5,100
+3,960
+347% +$320K ﹤0.01% 5686
2021
Q2
$116K Sell
1,140
-912
-44% -$92.4K ﹤0.01% 6289
2021
Q1
$207K Buy
2,052
+386
+23% +$39.6K ﹤0.01% 5642
2020
Q4
$184K Buy
+1,666
New +$177K ﹤0.01% 5635
2020
Q2
Sell
-35
Closed -$3K 6608
2020
Q1
$3K Sell
35
-83
-70% -$8.21K ﹤0.01% 6318
2019
Q4
$12K Buy
+118
New +$11.7K ﹤0.01% 6216

Other funds holding CELU